SEC Form 4 · accession 0001209191-16-116007
Arcadia Biosciences, Inc. · RKDA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven F. Brandwein
Officer — Interim Chief Financ. Officer
Period of report
Apr 25, 2016
Accepted (ET)
Apr 27, 2016 · 7:35 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001469443
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2,F3 | Apr 25, 2016 | S | 1,720 | $2.424 | D | 9,030 | D | |
| Common Stock | holding | — | — | — | 39,965 | I | by Steven Franklin Brandwein Living Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The security transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 Stock Trading Plan (the "Plan"), adopted by the Reporting Person effective December 11, 2015, as amended March 14, 2016.
- F2This transaction was executed in multiple trades at prices ranging from $2.40 to $2.45. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3Includes 750 shares acquired under the Issuer's 2015 Employee Stock Purchase Plan on February 1, 2016.